Latest Breaking News On - Herriot tabuteau - Page 8 : comparemela.com

Mizuho Securities Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM)

Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) today and set a price .

Morgan Stanley Reaffirms Their Hold Rating on Axsome Therapeutics (AXSM)

In a report released on March 24, Vikram Purohit from Morgan Stanley maintained a Hold rating on Axsome Therapeutics (AXSM – Research Repo.

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2022 Earnings Call Transcript

Operator: Good morning, and welcome to the Axsome Therapeutics Conference Call. Currently, all participants are in listen-only mode.

Form 8-K Axsome Therapeutics, For: Feb 27

Axsome Therapeutics (AXSM) Q4 2022 Earnings Call Transcript

AXSM earnings call for the period ending December 31, 2022.